Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
3.910
-0.020 (-0.51%)
At close: Jun 18, 2026, 4:00 PM EDT
3.920
+0.010 (0.26%)
After-hours: Jun 18, 2026, 7:48 PM EDT
Iovance Biotherapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $9 | Buy | Reiterates | $9 | +130.18% | Jun 4, 2026 |
| Barclays | Barclays | Buy Maintains $11 | Buy | Maintains | $11 | +181.33% | Jun 2, 2026 |
| Chardan Capital | Chardan Capital | Buy Reiterates $14 | Buy | Reiterates | $14 | +258.06% | May 8, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $5 | Buy | Maintains | $5 | +27.88% | May 7, 2026 |
Unknown Analyst Mizuho Securities No rating | Mizuho Securities | Buy Maintains $10 | Buy | Maintains | $10 | +155.75% | Mar 30, 2026 |
| UBS | UBS | Hold Reiterates $2 → $4 | Hold | Reiterates | $2 → $4 | +2.30% | Mar 5, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $14 | Buy | Reiterates | $14 | +258.06% | Feb 26, 2026 |
| Robert W. Baird | Robert W. Baird | Hold Maintains $3 → $4 | Hold | Maintains | $3 → $4 | +2.30% | Feb 25, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.